Phase 2 Study of Gemzar, Taxol & Avastin Combination as 1st Line Treatment for Metastatic Breast Cancer
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
Single-institution phase 2 trial investigating the efficacy of capecitabine, oxaliplatin and
bevacizumab for patients with metastatic neuroendocrine tumors.